PwC Polska congratulates Diagnostyka S.A. on its successful debut on the Warsaw Stock Exchange (GPW). We are proud to have been part of this journey, supporting the company in key areas such as IPO preparation coordination, financial reporting, legal and tax advisory, compliance, and IT.
Diagnostyka S.A.’s Initial Public Offering (IPO) garnered significant investor interest, resulting in an offering valued at nearly PLN 1.7 billion. It is the first successfully completed IPO in Europe this year and one of the largest public offerings in Poland in recent years.
“Diagnostyka’s debut on the Warsaw Stock Exchange marks a milestone in our history. The success of the IPO, backed by strong investor demand, underscores the strength of our business model and confidence in our growth strategy. We extend our gratitude to everyone who contributed to this achievement – our employees, partners, and advisors. We now enter a new phase where we will continue to expand our offering and deliver top-quality diagnostic services” – said Jakub Swadźba, co-founder and CEO of Diagnostyka S.A.
“Preparing for and executing an IPO is a transformative milestone for Diagnostyka, reshaping our operations, financial reporting, stakeholder communication, and strategic planning. As a publicly listed company, we are committed to engaging with investors and transparently communicating our values and vision for growth” – said Paweł Chytła, CFO of Diagnostyka S.A.
“Congratulations to Diagnostyka S.A., its founders, shareholders, management, and supervisory board on the success of the public offering and stock market debut. Your dedication to creating value for both customers and investors is truly commendable” – said Małgorzata Górna, Partner at PwC Polska.
PwC Polska’s Multidisciplinary IPO Advisory Team:
- Małgorzata Górna – Partner, Value Creation
- Mike Wilder – Partner, Relationship Partner
- Bartosz Margol – Partner, Capital Markets & Financial Reporting
- Piotr Niewiadomski – Partner, Tax Advisory
- Piotr Woźniakiewicz – Partner, Tax Advisory
- Angelika Ciastek-Zyska – Director, Compliance
- Bartłomiej Kołodziejczyk – Director, Technology Consulting
- Marta Wilk – Senior Manager, Accounting Advisory & Integrated Reporting
- Paulina Foks – Senior Manager, Capital Markets
- Kamil Wardzyński – Director, Capital Markets
- Klaudia Kłapyta – Director, Capital Markets
- Monika Jeleń-Osiecka – Director, Actuarial Valuations
“Diagnostyka’s IPO was met with exceptional investor interest, demonstrating the strength of its equity story and its readiness for the public market. For Poland’s capital market, this is an outstanding start to the year – the listing of Diagnostyka reinforces the Warsaw Stock Exchange’s position as a key and active market for large-scale IPOs” – said Bartosz Margol, Partner at PwC Polska, Capital Markets & Financial Reporting.
This milestone transaction highlights the resilience and attractiveness of the Polish capital market, and we at PwC Polska are honored to have supported Diagnostyka S.A. in this landmark achievement.
